AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, has announced it will collaborate with Mawi, a medtech provider of medical grade wearables in the cardiac space, to integrate its proprietary ECG analytics into Mawi’s cardiac monitoring watch.
As part of the collaboration, AccurKardia’s innovation in device agnostic automated ECG analytics will complement Mawi’s proven expertise in designing, developing and deploying superior cardiac monitoring devices and wearables, AccurKardia said in a press release. The joint offering will enable the early detection of potentially life-threatening cardiovascular conditions that may be otherwise missed or diagnosed at a late stage, the press release adds.
“Joining forces will provide our new Mawi Watch with next level ECG analytics as we create a fully integrated solution for chronic patients’ cardiac remote monitoring,” said Ron Fridman, the chief executive officer of Mawi. “We are on a mission to beat the heart’s ‘silent killers’ and our new cardiac monitoring solution will empower clinicians at all stages of patient management, identifying cardiovascular issues earlier and more effectively.”
“We are excited to work with Mawi, an innovative medtech player developing a new generation of cardiac monitoring devices and wearables. Both AccurKardia and Mawi have a shared goal of improving patient outcomes through superior remote patient monitoring solutions,” said Juan C Jiménez, chief executive officer of AccurKardia. “By equipping the next generation of wearables with automated ECG analysis capabilities, together we are raising the bar in cardiovascular health monitoring, improving access to quality care and ultimately saving lives.”
